Female Infertility Global Market Report 2025

Global Female Infertility Market Report 2025

Female Infertility Global Market Report 2025 – By Treatment (Clomiphene Citrate, Gonadotropins, Metformin, Letrozole, Bromocriptine), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By End-User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

Name: Female Infertility Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Female Infertility Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Female Infertility Global Market Report 2025

Proud Members Of

Female Infertility Market Definition

Female infertility is defined as the inability of a woman to conceive after 12 months of regular, unprotected sexual intercourse (or 6 months for women aged 35 or older) or the inability to carry a pregnancy to term. It is a complex condition resulting from various factors affecting the reproductive system.

The main treatments for female infertility include clomiphene citrate, gonadotropins, metformin, letrozole, and bromocriptine. Clomiphene citrate is a medication commonly used to treat female infertility by stimulating ovulation. It can be administered through various routes, such as oral, parenteral, and others, and is used by hospital pharmacies, retail pharmacies, and online pharmacies.

Female Infertility Market Segmentation

The female infertility market covered in this report is segmented –

1) By Treatment: Clomiphene Citrate, Gonadotropins, Metformin, Letrozole, Bromocriptine

2) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

3) By End-User: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Clomiphene Citrate: Oral Clomiphene Citrate, Injectable Clomiphene Citrate

2) By Gonadotropins: Recombinant Gonadotropins, Urinary Gonadotropins, Human Chorionic Gonadotropin (hCG)

3) By Metformin: Immediate-Release Metformin, Extended-Release Metformin

4) By Letrozole: Oral Letrozole Tablets, Injectable Letrozole

5) By Bromocriptine: Oral Bromocriptine Tablets, Intranasal Bromocriptine

Female Infertility Market Size and growth rate 2025 to 2029: Graph

Female Infertility Market Size 2025 And Growth Rate

The female infertility market size has grown steadily in recent years. It will grow from $1.79 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to growing trend of women delaying childbirth, increasing changes in lifestyle, increasing government initiatives, rising aging population, increasing assisted reproductive technology (ART) treatment.

Female Infertility Market Growth Forecast

The female infertility market size is expected to see steady growth in the next few years. It will grow to $2.19 billion in 2029 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to rising awareness of fertility issues, increasing cases of polycystic ovary syndrome, rising cases of uterine abnormalities, rising incidence of genetic disorders, increasing obesity. Major trends in the forecast period include advancements in preimplantation genetic testing, technological advancement, novel technologies for diagnosis, fertility preservation, and telemedicine.

Book your 30 minutes free consultation with our research experts

Female Infertility Market Driver: Rising Infertility Trends Driving Demand For Advanced Treatments

The increasing prevalence of infertility is expected to propel the growth of the female infertility market going forward. Infertility is the inability to conceive after 12 months of regular, unprotected sexual intercourse. Increasing infertility is driven by factors such as delayed childbearing, lifestyle changes, environmental toxins, rising obesity, and higher stress levels. Female infertility treatment is required to address and manage underlying medical, hormonal, or structural issues that impair fertility, thereby enhancing the chances of conception and preventing permanent infertility. For instance, in July 2024, according to the Human Fertilization and Embryology Authority, a UK-based non-departmental public body of the Department of Health and Social Care, licensed fertility clinics in the UK performed nearly 77,000 fresh and frozen embryo transfer IVF cycles for 52,500 patients in 2022. Over 90% of these patients underwent treatment with a partner, involving approximately 100,000 individuals. Therefore, the increasing prevalence of infertility drives the growth of the female infertility market.

Global Female Infertility Market Major Players

Major companies operating in the female infertility market are Pfizer Inc., Roche Holding AG, Merck And Co. Inc, Bayer AG, Sanofi S.A., AstraZeneca Plc, Abbott Laboratories, Mayo Clinic, Teva Pharmaceutical Industries Ltd, Commonwealth Serum Laboratories Ltd, Organon Theramex, Juniper Reproductive Health Ltd., Sumitomo Pharma, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Co., Mankind Pharma, Kissei Pharmaceutical Co Ltd, ASKA Pharmaceutical Co. Ltd., Fuji Pharma Co. Ltd., ARMC IVF, Zydus Cadila Healthcare, IBSA Institut Biochimique, Oxolife, Ava AG, Hernova Lifesciences Holdings Ltd

Global Female Infertility Market Trend: Technological Advancements In Market With Non-Invasive Diagnostic Tests

Major companies operating in the female infertility market are focusing on developing innovative products, such as non-invasive diagnostic tests, to gain a competitive edge in the industry. A non-invasive diagnostic test is a medical test that detects conditions or diseases without requiring surgery or penetration of the body. For instance, in August 2024, Heranova Lifesciences, a US-based biotech company, launched an early access program for HerResolve, a non-invasive diagnostic test for endometriosis. Endometriosis affects about 200 million women worldwide, causing symptoms like infertility, pain, and bleeding. For many women, an accurate diagnosis takes an average of 7-10 years from the onset of symptoms, mainly due to the varied symptom presentation and the invasive nature of the most reliable diagnostic method, exploratory laparoscopic surgery. HerResolve potentially reduces this diagnostic delay from years to months, leading to better patient and healthcare outcomes. HerResolve aims to shorten this timeline significantly, improving patient care and outcomes.

Female Infertility Market Merger And Acquisition: CCRM Fertility Expands East Coast Presence With Acquisition Of The New Hope Center For Reproductive Medicine

In April 2023, CCRM Fertility, a US-based fertility clinic network, acquired the New Hope Center for Reproductive Medicine for an undisclosed amount. With this acquisition, CCRM expands fertility's presence on the East Coast, providing easier access to top-tier fertility care, advanced testing, state-of-the-art labs, and in-house genetics and research, ensuring leading success rates. The New Hope Center for Reproductive Medicine is a US-based a fertility clinic that offers a range of services, including in vitro fertilization (IVF) to overcome female infertility.

Regional Outlook For The Global Female Infertility Market

Europe was the largest region in the female infertility market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the female infertility market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the female infertility market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Female Infertility Market?

The female infertility market consists of revenues earned by entities by providing services such as hormonal therapy and treatment, genetic testing and counseling, ovulation induction, egg and sperm donation and intrauterine insemination. The market value includes the value of related goods sold by the service provider or included within the service offering. The female infertility market also includes sales of fertility drugs, ovulation test kits, fertility supplements, insemination devices and ultrasound machines for fertility monitoring. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Female Infertility Industry?

The female infertility market research report is one of a series of new reports from The Business Research Company that provides female infertility market statistics, including female infertility industry global market size, regional shares, competitors with a female infertility market share, detailed female infertility market segments, market trends and opportunities, and any further data you may need to thrive in the female infertility industry. This female infertility market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Female Infertility Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	1.87 billion
Revenue Forecast In 2034	$2.19 billion
Growth Rate	CAGR of 4.1% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The female infertility market covered in this report is segmented – 1) By Treatment: Clomiphene Citrate, Gonadotropins, Metformin, Letrozole, Bromocriptine 2) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations 3) By End-User: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy Subsegments: 1) By Clomiphene Citrate: Oral Clomiphene Citrate, Injectable Clomiphene Citrate 2) By Gonadotropins: Recombinant Gonadotropins, Urinary Gonadotropins, Human Chorionic Gonadotropin (hCG) 3) By Metformin: Immediate-Release Metformin, Extended-Release Metformin 4) By Letrozole: Oral Letrozole Tablets, Injectable Letrozole 5) By Bromocriptine: Oral Bromocriptine Tablets, Intranasal Bromocriptine
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Roche Holding AG, Merck And Co. Inc, Bayer AG, Sanofi S.A., AstraZeneca Plc, Abbott Laboratories, Mayo Clinic, Teva Pharmaceutical Industries Ltd, Commonwealth Serum Laboratories Ltd, Organon Theramex, Juniper Reproductive Health Ltd., Sumitomo Pharma, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Co., Mankind Pharma, Kissei Pharmaceutical Co Ltd, ASKA Pharmaceutical Co. Ltd., Fuji Pharma Co. Ltd., ARMC IVF, Zydus Cadila Healthcare, IBSA Institut Biochimique, Oxolife, Ava AG, Hernova Lifesciences Holdings Ltd
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Female Infertility Market Characteristics

3. Female Infertility Market Trends And Strategies

4. Female Infertility Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Female Infertility Growth Analysis And Strategic Analysis Framework

5.1. Global Female Infertility PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Female Infertility Market Growth Rate Analysis

5.4. Global Female Infertility Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Female Infertility Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Female Infertility Total Addressable Market (TAM)

6. Female Infertility Market Segmentation

6.1. Global Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clomiphene Citrate

Gonadotropins

Metformin

Letrozole

Bromocriptine

6.2. Global Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

Other Route Of Administrations

6.3. Global Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

6.4. Global Female Infertility Market, Sub-Segmentation Of Clomiphene Citrate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Clomiphene Citrate

Injectable Clomiphene Citrate

6.5. Global Female Infertility Market, Sub-Segmentation Of Gonadotropins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Recombinant Gonadotropins

Urinary Gonadotropins

Human Chorionic Gonadotropin (hCG)

6.6. Global Female Infertility Market, Sub-Segmentation Of Metformin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immediate-Release Metformin

Extended-Release Metformin

6.7. Global Female Infertility Market, Sub-Segmentation Of Letrozole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Letrozole Tablets

Injectable Letrozole

6.8. Global Female Infertility Market, Sub-Segmentation Of Bromocriptine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Bromocriptine Tablets

Intranasal Bromocriptine

7. Female Infertility Market Regional And Country Analysis

7.1. Global Female Infertility Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Female Infertility Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Female Infertility Market

8.1. Asia-Pacific Female Infertility Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Female Infertility Market

9.1. China Female Infertility Market Overview

9.2. China Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Female Infertility Market

10.1. India Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Female Infertility Market

11.1. Japan Female Infertility Market Overview

11.2. Japan Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Female Infertility Market

12.1. Australia Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Female Infertility Market

13.1. Indonesia Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Female Infertility Market

14.1. South Korea Female Infertility Market Overview

14.2. South Korea Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Female Infertility Market

15.1. Western Europe Female Infertility Market Overview

15.2. Western Europe Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Female Infertility Market

16.1. UK Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Female Infertility Market

17.1. Germany Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Female Infertility Market

18.1. France Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Female Infertility Market

19.1. Italy Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Female Infertility Market

20.1. Spain Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Female Infertility Market

21.1. Eastern Europe Female Infertility Market Overview

21.2. Eastern Europe Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Female Infertility Market

22.1. Russia Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Female Infertility Market

23.1. North America Female Infertility Market Overview

23.2. North America Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Female Infertility Market

24.1. USA Female Infertility Market Overview

24.2. USA Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Female Infertility Market

25.1. Canada Female Infertility Market Overview

25.2. Canada Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Female Infertility Market

26.1. South America Female Infertility Market Overview

26.2. South America Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Female Infertility Market

27.1. Brazil Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Female Infertility Market

28.1. Middle East Female Infertility Market Overview

28.2. Middle East Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Female Infertility Market

29.1. Africa Female Infertility Market Overview

29.2. Africa Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Female Infertility Market Competitive Landscape And Company Profiles

30.1. Female Infertility Market Competitive Landscape

30.2. Female Infertility Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Female Infertility Market Other Major And Innovative Companies

31.1. AstraZeneca Plc

31.2. Abbott Laboratories

31.3. Mayo Clinic

31.4. Teva Pharmaceutical Industries Ltd

31.5. Commonwealth Serum Laboratories Ltd

31.6. Organon Theramex

31.7. Juniper Reproductive Health Ltd.

31.8. Sumitomo Pharma

31.9. Ferring Pharmaceuticals

31.10. Livzon Pharmaceutical Group Co.

31.11. Mankind Pharma

31.12. Kissei Pharmaceutical Co Ltd

31.13. ASKA Pharmaceutical Co. Ltd.

31.14. Fuji Pharma Co. Ltd.

31.15. ARMC IVF

32. Global Female Infertility Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Female Infertility Market

34. Recent Developments In The Female Infertility Market

35. Female Infertility Market High Potential Countries, Segments and Strategies

35.1 Female Infertility Market In 2029 - Countries Offering Most New Opportunities

35.2 Female Infertility Market In 2029 - Segments Offering Most New Opportunities

35.3 Female Infertility Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Female Infertility Market, Sub-Segmentation Of Clomiphene Citrate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Female Infertility Market, Sub-Segmentation Of Gonadotropins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Female Infertility Market, Sub-Segmentation Of Metformin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Female Infertility Market, Sub-Segmentation Of Letrozole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Female Infertility Market, Sub-Segmentation Of Bromocriptine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Female Infertility Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Female Infertility Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Pfizer Inc. Financial Performance

Table 80: Roche Holding AG Financial Performance

Table 81: Merck & Co. Inc. Financial Performance

Table 82: Bayer AG Financial Performance

Table 83: Sanofi S.A. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Female Infertility Market, Sub-Segmentation Of Clomiphene Citrate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Female Infertility Market, Sub-Segmentation Of Gonadotropins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Female Infertility Market, Sub-Segmentation Of Metformin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Female Infertility Market, Sub-Segmentation Of Letrozole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Female Infertility Market, Sub-Segmentation Of Bromocriptine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Female Infertility Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Female Infertility Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Female Infertility Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Female Infertility Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Female Infertility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Pfizer Inc. Financial Performance

Figure 80: Roche Holding AG Financial Performance

Figure 81: Merck & Co. Inc. Financial Performance

Figure 82: Bayer AG Financial Performance

Figure 83: Sanofi S.A. Financial Performance

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

What Is The Healthcare IT Consulting Market Overview In 2022?

How Will The Stem Cell Assay Market Grow In 2022?

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Female Fertility And Pregnancy Rapid Test Global Market Report 2025 – By Product (Fertility Rapid Test Kits, Pregnancy Rapid Test Kits), By Device Type (Digital Devices, Line-indicator Devices), By Test Type (FSH Urine Test, LH Urine Test, hCG Blood Test, hCG Urine Test), By Distribution Channel (Hospital Channel, Retail Channel, Online Channel ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pregnancy Test Kits Global Market Report 2025 – By Type (Blood Test For Human Chorionic Gonadotropin (HCG), Urine Test For Human Chorionic Gonadotropin (HCG)), By Distribution Channel (Retail, Online), By Application (Hospitals, Clinics, Households, Pharmacies), By End-Users (Professionals, Home-Based) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Assisted Reproductive Technology Global Market Report 2025 – By Diagnosis (Ovulation Testing, Hysterosalpingography, Ovarian Reserve Testing, Genetic Testing), By Procedure Type (Fresh Non-Donor, Fresh Donor, Frozen Donor, Frozen Non-Donor, Embryo Or Egg Banking), By End-User (Hospitals, Fertility Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Women’s Health Devices Global Market Report 2025 – By Product (Surgical, Diagnostics, Contraceptives, Labor and Delivery, Critical Care), By Type (Devices, Consumables), By Application (Cancer, Osteoporosis, Infectious Disease, Uterine Fibroids, Post-menopausal Syndrome, Pregnancy, Female Sterilization, Other Applications), By End-user (Hospitals, Obstetrics and Gynecology Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Women's Health Global Market Report 2025 – By Product Type( Devices, Drugs, Pharmaceutical Pipeline), By Age( 50 Years & above , Other Ages), By Treatment Type( Hormonal Treatment, Non-Hormonal Treatment, Surgeries), By Application( Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis & Uterine Fibroids, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS)), By Distribution Channel( Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Women’s Health And Beauty Supplements Global Market Report 2025 – By Product( Vitamins, Mineral, Enzymes, Botanicals, Proteins, Omega-3, Probiotics, Other Products), By Consumer Group( Prenatal, Postnatal, PMS (Premenstrual Syndrome), Perimenopause, Postmenopause, Other Consumer Group), By Distribution Channel( Hypermarkets And Supermarkets, Health And Beauty Retail Stores, Drug Stores, Online Pharmacies And E-Commerce Sites ), By Application( Beauty, Women's Health ), By End-Users Age Group( Below 18 Years, 18 Years - 36 Years, 36 Years – 54 Years, 54 Years And Above) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Women's Digital Health Global Market Report 2025 – By Type (Mobile Apps, Wearable Devices, Diagnostic Tools, Other Types Consumable, Instruments, Services), By Component (Software, Services, Hardware), By Application (Reproductive Health, General Healthcare, Wellness, Pregnancy, Nursing Care, Pelvic Care) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Womens Health Diagnostics Global Market Report 2025 – By Type (Accessories And Consumables, Diagnostic Tests, Diagnostic Devices), By Application (Osteoporosis Testing, Ovarian Cancer Testing (OVC), Cervical Cancer Testing, Breast Cancer Testing, Pregnancy And Fertility Testing, Prenatal Genetic Screening And Carrier Testing, Infectious Disease Testing, Sexually Transmitted Diseases (STD) Testing, Ultrasound Tests), By End User (Hospitals And Clinics, Diagnostic And Imaging Centers, Homecare, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Female Infertility market?

How will the Female Infertility market drivers and restraints affect the market dynamics? What forces will shape the Female Infertility industry going forward?

The Female Infertility market major growth driver - Rising Infertility Trends Driving Demand For Advanced Treatments. For further insights on the Female Infertility market, request a sample here

What is the forecast market size or the forecast market value of the Female Infertility market?

The Female Infertility market size has grown strongly in recent years. The female infertility market size has grown steadily in recent years. It will grow from $1.79 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to growing trend of women delaying childbirth, increasing changes in lifestyle, increasing government initiatives, rising aging population, increasing assisted reproductive technology (ART) treatment. The female infertility market size is expected to see steady growth in the next few years. It will grow to $2.19 billion in 2029 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to rising awareness of fertility issues, increasing cases of polycystic ovary syndrome, rising cases of uterine abnormalities, rising incidence of genetic disorders, increasing obesity. Major trends in the forecast period include advancements in preimplantation genetic testing, technological advancement, novel technologies for diagnosis, fertility preservation, and telemedicine. For further insights on the Female Infertility market, request a sample here

How is the Female Infertility market segmented?

The female infertility market covered in this report is segmented –
1) By Treatment: Clomiphene Citrate, Gonadotropins, Metformin, Letrozole, Bromocriptine
2) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
3) By End-User: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy Subsegments:
1) By Clomiphene Citrate: Oral Clomiphene Citrate, Injectable Clomiphene Citrate
2) By Gonadotropins: Recombinant Gonadotropins, Urinary Gonadotropins, Human Chorionic Gonadotropin (hCG)
3) By Metformin: Immediate-Release Metformin, Extended-Release Metformin
4) By Letrozole: Oral Letrozole Tablets, Injectable Letrozole
5) By Bromocriptine: Oral Bromocriptine Tablets, Intranasal Bromocriptine For further insights on the Female Infertility market, request a sample here

Which region has the largest share of the Female Infertility market? What are the other regions covered in the report?

Who are the major players in the Female Infertility market?

What are the key trends in the Female Infertility market?

Major trends in the Female Infertility market include Technological Advancements In Market With Non-Invasive Diagnostic Tests. For further insights on the Female Infertility market, request a sample here.

What are the major opportunities in the Female Infertility market? What are the strategies for the Female Infertility market?

For detailed insights on the major opportunities and strategies in the Female Infertility market, request a sample here.

How does the Female Infertility market relate to the overall economy and other similar markets?

For detailed insights on Female Infertility's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Female Infertility industry?

For detailed insights on the mergers and acquisitions in the Female Infertility industry, request a sample here.

What are the key dynamics influencing the Female Infertility market growth? SWOT analysis of the Female Infertility market.

For detailed insights on the key dynamics influencing the Female Infertility market growth and SWOT analysis of the Female Infertility industry, request a sample here.